Language:English
Language:

Xcessbio

Place your promotion here

You have no items in your shopping cart.

HG-10-102-01, LRRK2 Inhibitor

HG-10-102-01, LRRK2 Inhibitor

$139.00
A brain penetrant potent and selective inhibitor of wild-type LRRK2 and the G2019S mutant.
Catalog No. Unit Price Qty
M60061-2s 2mg solid $139.00
M60061-2 10 mM in DMSO (0.529 mL) $139.00
M60061-50s 50mg solid $1200.00

Details

Product Information
Molecular Weight: 377.83
Formula: C17H20ClN5O3
Purity: ≥98%
CAS#: 1351758-81-0
Solubility: DMSO up to 100 mM
Chemical Name: (4-((5-chloro-4-(methylamino)pyrimidin-2-yl)amino)-3-methoxyphenyl)(morpholino)methanone
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

HG-10-102-01 is a brain penetrant, potent and selective inhibitor of wild-type LRRK2 and the G2019S mutant (IC50 for LRRK2-wild-type ~20.3 nM and LRRK2-[G2019S] ~3.2 nM). It significantly inhibits Ser910 and Ser935 phosphorylation of both wild-type LRRK2 and G2019S mutant at a concentration of 0.1−0.3 μM in cells. HG-10-102-01 is the first compound reported to be capable of inhibiting Ser910 and Ser935 phosphorylation in mouse brain following intraperitoneal delivery of doses as low as 50 mg/kg. It may represent a good lead compound for a subset of Parkinson's disease. 

 

How to Use:

  • In vitro:  HG-10-102-01was used at 0.3-1.0 µM final concentration in vitro and in cellular assays.
  • In vivo: HG-10-102-01 was intraperitoneally (IP) dosed to mice at 50 mg/kg once per day.

 

Reference:

  • 1. Choi HG, et al. Brain Penetrant LRRK2 Inhibitorn (2012) ACS Med. Chem. Lett., 2012, 3 (8), 658–662.
  • 2. Chen H, et al. Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling. (2012) Journal of Medicinal Chemistry. 55(11), 5536-5545.

 


        


Products are for research use only. Not for human use.

Description

Details

Product Information
Molecular Weight: 377.83
Formula: C17H20ClN5O3
Purity: ≥98%
CAS#: 1351758-81-0
Solubility: DMSO up to 100 mM
Chemical Name: (4-((5-chloro-4-(methylamino)pyrimidin-2-yl)amino)-3-methoxyphenyl)(morpholino)methanone
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

HG-10-102-01 is a brain penetrant, potent and selective inhibitor of wild-type LRRK2 and the G2019S mutant (IC50 for LRRK2-wild-type ~20.3 nM and LRRK2-[G2019S] ~3.2 nM). It significantly inhibits Ser910 and Ser935 phosphorylation of both wild-type LRRK2 and G2019S mutant at a concentration of 0.1−0.3 μM in cells. HG-10-102-01 is the first compound reported to be capable of inhibiting Ser910 and Ser935 phosphorylation in mouse brain following intraperitoneal delivery of doses as low as 50 mg/kg. It may represent a good lead compound for a subset of Parkinson's disease. 

 

How to Use:

  • In vitro:  HG-10-102-01was used at 0.3-1.0 µM final concentration in vitro and in cellular assays.
  • In vivo: HG-10-102-01 was intraperitoneally (IP) dosed to mice at 50 mg/kg once per day.

 

Reference:

  • 1. Choi HG, et al. Brain Penetrant LRRK2 Inhibitorn (2012) ACS Med. Chem. Lett., 2012, 3 (8), 658–662.
  • 2. Chen H, et al. Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling. (2012) Journal of Medicinal Chemistry. 55(11), 5536-5545.

 


        


Products are for research use only. Not for human use.

Reviews

Write Your Review

How do you rate this product? *

Price:
Value:
Quality: